These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Cellular co-localization of phosphorylated tau- and NACP/alpha-synuclein-epitopes in lewy bodies in sporadic Parkinson's disease and in dementia with Lewy bodies. Arima K; Hirai S; Sunohara N; Aoto K; Izumiyama Y; Uéda K; Ikeda K; Kawai M Brain Res; 1999 Oct; 843(1-2):53-61. PubMed ID: 10528110 [TBL] [Abstract][Full Text] [Related]
7. Active, phosphorylation-dependent mitogen-activated protein kinase (MAPK/ERK), stress-activated protein kinase/c-Jun N-terminal kinase (SAPK/JNK), and p38 kinase expression in Parkinson's disease and Dementia with Lewy bodies. Ferrer I; Blanco R; Carmona M; Puig B; Barrachina M; Gómez C; Ambrosio S J Neural Transm (Vienna); 2001; 108(12):1383-96. PubMed ID: 11810403 [TBL] [Abstract][Full Text] [Related]
8. Parkinson's disease: the thalamic components of the limbic loop are severely impaired by alpha-synuclein immunopositive inclusion body pathology. Rüb U; Del Tredici K; Schultz C; Ghebremedhin E; de Vos RA; Jansen Steur E; Braak H Neurobiol Aging; 2002; 23(2):245-54. PubMed ID: 11804710 [TBL] [Abstract][Full Text] [Related]
9. Neuroinflammation and protein pathology in Parkinson's disease dementia. Kouli A; Camacho M; Allinson K; Williams-Gray CH Acta Neuropathol Commun; 2020 Dec; 8(1):211. PubMed ID: 33272323 [TBL] [Abstract][Full Text] [Related]
10. Alpha-synuclein-positive structures in association with diffuse neurofibrillary tangles with calcification. Hishikawa N; Hashizume Y; Ujihira N; Okada Y; Yoshida M; Sobue G Neuropathol Appl Neurobiol; 2003 Jun; 29(3):280-7. PubMed ID: 12787325 [TBL] [Abstract][Full Text] [Related]
11. Colocalization of tau and alpha-synuclein epitopes in Lewy bodies. Ishizawa T; Mattila P; Davies P; Wang D; Dickson DW J Neuropathol Exp Neurol; 2003 Apr; 62(4):389-97. PubMed ID: 12722831 [TBL] [Abstract][Full Text] [Related]
12. Tau pathology in the olfactory bulb correlates with Braak stage, Lewy body pathology and apolipoprotein epsilon4. Tsuboi Y; Wszolek ZK; Graff-Radford NR; Cookson N; Dickson DW Neuropathol Appl Neurobiol; 2003 Oct; 29(5):503-10. PubMed ID: 14507342 [TBL] [Abstract][Full Text] [Related]
13. Alpha-synuclein pathology in Parkinson's and Alzheimer's disease brain: incidence and topographic distribution--a pilot study. Jellinger KA Acta Neuropathol; 2003 Sep; 106(3):191-201. PubMed ID: 12845452 [TBL] [Abstract][Full Text] [Related]
14. Lewy body-related alpha-synucleinopathy in the aged human brain. Jellinger KA J Neural Transm (Vienna); 2004 Oct; 111(10-11):1219-35. PubMed ID: 15480835 [TBL] [Abstract][Full Text] [Related]
15. Abeta deposition is associated with enhanced cortical alpha-synuclein lesions in Lewy body diseases. Pletnikova O; West N; Lee MK; Rudow GL; Skolasky RL; Dawson TM; Marsh L; Troncoso JC Neurobiol Aging; 2005; 26(8):1183-92. PubMed ID: 15917102 [TBL] [Abstract][Full Text] [Related]
16. Neuritic degeneration in the hippocampus and amygdala in Parkinson's disease in relation to Alzheimer pathology. Mattila PM; Rinne JO; Helenius H; Röyttä M Acta Neuropathol; 1999 Aug; 98(2):157-64. PubMed ID: 10442555 [TBL] [Abstract][Full Text] [Related]
17. [Parkinson's disease, dementia with Lewy bodies, multiple system atrophy and alpha-synuclein]. Iwatsubo T Rinsho Shinkeigaku; 1999 Dec; 39(12):1285-6. PubMed ID: 10791099 [TBL] [Abstract][Full Text] [Related]
18. Lewy body densities in the entorhinal and anterior cingulate cortex predict cognitive deficits in Parkinson's disease. Kövari E; Gold G; Herrmann FR; Canuto A; Hof PR; Bouras C; Giannakopoulos P Acta Neuropathol; 2003 Jul; 106(1):83-8. PubMed ID: 12687392 [TBL] [Abstract][Full Text] [Related]